+353 (0) 1 963 1347
14 Fitzwilliam Square
Republic of Ireland
Satipharm is a health & wellbeing company which is specialized in the development and manufacture of cannabinoid-based products from the cannabis plant. The Satipharm manufacturing process is in line with the international standards of Good Manufacturing Practice (GMP). This ensures that Satipharm only provides products of exceptional, consistent quality, that are manufactured in a regulated, safe environment.
Satipharm believes commercialization of its signature, patented Gelpell® technology for cannabinoid products with clinically proven superior bioavailability will transform the company into a global leader in the medical and health-based cannabis industry. Satipharm is dedicated to growing its portfolio of delivery technology IP with further expansion plans targeting introduction of other formulations including THC.
For more about Satipharm and its CBD Gelpell® technology, visit www.satipharm.com